Abstract
Evidence that membrane-bound and extracellular heat shock proteins (HSPs) with molecular weights of 70 and 90 kDa are potent stimulators of the immune responses has accumulated over the last decade. In this review, we discuss the modulation of Hsp70 expression, a major stress-inducible member of the HSP70 family, in the cytoplasm and on the plasma membrane of tumor cells by clinically applied interventions such as radio- and chemotherapy.
Similar content being viewed by others
Abbreviations
- 13-RA:
-
13-cis-retinoic acid
- ALL:
-
acute lymphoid leukemia
- AML:
-
acute myeloid leukemia
- APC(s):
-
antigen presenting cell(s)
- APL:
-
acute promyelocytic leukemia
- ARA-CTP:
-
arabinosyl-cytosin-triphosphate
- ASA:
-
acetyl-salicylic acid
- ATRA:
-
all-trans-retinoic acid
- B-CLL:
-
B cell chronic lymphoid leukemia
- CD:
-
cluster of differentiation (nomenclature for surface proteins of human leucocytes)
- CLX:
-
celecoxib
- COX:
-
cyclooxygenase
- ER:
-
endoplasmic reticulum
- Hsp:
-
heat shock protein
- IL:
-
interleukin
- NCR:
-
natural cytotoxicity receptor
- NHL:
-
non-Hodgkin lymphoma
- NK:
-
natural killer cell
- NKG2D:
-
C-type lectin-like immunoreceptor on NK cells
- NKT cells:
-
natural killer-like T cells
- PI3K:
-
phosphatidyl-inositol-3-phosphat kinase
- PIO:
-
pioglitazone
- PIPLC:
-
phosphatidyl-inositol-specific phospholipase C
- PKC:
-
protein kinase C
- RFX:
-
rofecoxib
- SBU:
-
sodium butyrate
- TKD:
-
14-mer Hsp70 peptide with the amino acid sequence T-K-D-N-N-L-L-G-R-F-E-L-S-G
- TLR:
-
Toll-like receptor
- TNF:
-
tumor necrosis factor
References
Abou-Issa HM, Alshafie GA, Seibert K, Koki AT, Masferrer JL, Harris RE (2001) Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis. Anticancer Res 21:3425–3432
Altucci L, Gronemeyer H (2001) Nuclear receptors in cell life and death. Trends Endocrinol Metab 12:460–468
Asea A, Kraeft SK, Kurt-Jones EA, Stevenson MA, Chen LB, Finberg RW, Koo GC, Calderwood SK (2000) HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med 6:435–442
Asea A, Rehli M, Kabingu E, Boch JA, Bare O, Auron PE, Stevenson MA, Calderwood SK (2002) Novel signal transduction pathway utilized by extracellular HSP70: role of Toll-like receptor (TLR) 2 and TLR4. J Biol Chem 277:15028–15034
Bandyopadhyay G, Laudanski K, Li F, Lentz C, Bankey P, Miller-Graziano C (2007) Negative signalling contributes to T cell energy in trauma patients. Crit Car Med 13:794–801
Barreto A, Gonzalez JM, Kabingu E, Asea A, Fiorentino S (2003) Stress-induced release of Hsc70 form human tumors. Cell Immunol 222:97–104
Basu S, Binder RJ, Ramalingam T, Srivastava PK (2001) CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14:303–313
Becker T, Hartl FU, Wieland F (2002) CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes. J Cell Biol 158:1277–1285
Blagosklonny MV, Fojo T (1999) Molecular effects of paclitaxel: myths and reality (a critical review). Int J Cancer 83:151–156
Botzler C, Kis K, Issels R, Multhoff G (1997) A comparison of the effects of ifosfamide vs. mafosfamide treatment on intracellular glutathione levels and immunological functions of immunocompetent lymphocyte subsets. Exp Hematol 25:338–344
Botzler C, Ellwart J, Gunther W, Eissner G, Multhoff G (1999) Synergistic effects of heat and ET-18-OCH3 on membrane expression of hsp70 and lysis of leukemic K562 cells. Exp Hematol 27:470–478
Brune K, Hinz B (2004) Selective cyclooxygenase-2 inhibitors: similarities and differences. Scand J Rheumatol 33:1–6
Calderwood SK, Theriault JR, Gong J (2005) Message in a bottle: role of the 70 kDa HSP in anti-tumor immunity. Eur J Cancer 35:2518–2527
Calderwood SK, Mambula SS, Gray PJ, Theriault JR (2007) Extracellular HSP in cell signalling. FEBS Lett 581:3689–3694
Callari D, Sinatra F, Paravizzini G et al (2003) All-trans retinoic acid sensitizes colon cancer cells to hyperthermia cytotoxic effects. Int J Oncol 23:181–188
Cao Y, Pearman AT, Zimmerman GA, McIntyre TM, Prescott SM (2000) Intracellular unesterified arachidonic acid signals apoptosis. Proc Natl Acad Sci U S A 97:11280–11285
Chen X, Tao Q, Yu H, Zhang L, Cao X (2002) Tumor cell membrane-bound Hsp70 elicits antitumor immunity. Immunol Lett 84:81–87
Ciocca DR, Calderwood SK (2005) Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10:86–103
Ciocca DR, Rozados VR, Cuello Carrion FD, Gervasoni SI, Matar P, Scharovsky OG (2003) Hsp25 and Hsp70 in rodent tumors treated with doxorubicin and lovastatin. Cell Stress Chaperones 8:26–36
Corley DA, Kerlikowske K, Verma R, Buffler P (2003) Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology 124:47–56
DeMaio A (2000) Heat shock proteins, oxygen radicals, and apoptosis: the conflict between protection and destruction. Crit Care Med 28:1679–1681
Dimanche-Boitrel MT, Meurette O, Rebillard A, Lacour S (2005) Role of early plasma membrane events in chemotherapy-induced cell death. Drug Resist Updat 8:5–14
Eissner G, Multhoff G, Gerbitz A, Kirchner S, Bauer S, Haffner S, Sondermann D, Andreesen R, Holler E (2002) Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide. Blood 100:334–340
Farrow DC, Vaughan TL, Hansten PD et al (1998) Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarker Prev 7:97–102
Freemantle SJ, Spinella MJ, Dmitrovsky E (2003) Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 22:7305–7315
Gabai VL, Meriin AB, Yaglom JA, Volloch VZ, Sherman MY (1998) Role of Hsp70 in regulation of stress-kinase JNK: implications in apoptosis and aging. FEBS Lett 438:1–4
Gehrmann M, Pfister K, Hutzler P, Gastpar R, Margulis B, Multhoff G (2002) Effects of antineoplastic agents on cytoplasmic and membrane-bound heat shock protein 70 (Hsp70) levels. Biol Chem 383:1715–1725
Gehrmann M, Schmetzer H, Eissner G, Haferlach T, Hiddemann W, Multhoff G (2003) Membrane-bound heat shock protein 70 (Hsp70) in acute myeloid leukemia: a tumor specific recognition structure for the cytolytic activity of autologous NK cells. Haematologica 88:474–476
Gehrmann M, Brunner M, Pfister K, Reichle A, Kremmer E, Multhoff G (2004) Differential up-regulation of cytosolic and membrane-bound heat shock protein 70 in tumor cells by anti-inflammatory drugs. Clin Cancer Res 10:3354–3364
Gehrmann M, Marienhagen J, Eichholtz-Wirth H, Fritz E, Ellwart J, Jaattela M, Zilch T, Multhoff G (2005a) Dual function of membrane-bound heat shock protein 70 (Hsp70), Bag-4, and Hsp40: protection against radiation-induced effects and target structure for natural killer cells. Cell Death Differ 12:38–51
Gehrmann M, Schonberger J, Zilch T, Rossbacher L, Thonigs G, Eilles C, Multhoff G (2005b) Retinoid- and sodium-butyrate-induced decrease in heat shock protein 70 membrane-positive tumor cells is associated with reduced sensitivity to natural killer cell lysis, growth delay, and altered growth morphology. Cell Stress Chaperones 10:136–146
Gendimenico GJ, Mezick JA (1993) Pharmacological effects of retinoids on skin cells. Skin Pharmacol 6(Suppl 1):24–34
Gidding CE, Kellie SJ, Kamps WA, de Graaf SS (1999) Vincristine revisited. Crit Rev Oncol Hematol 29:267–287
Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC (1994) Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 121:241–246
Grant S (1998) Ara-C: cellular and molecular pharmacology. Adv Cancer Res 72:197–233
Gross C, Koelch W, DeMaio A, Arispe N, Multhoff G (2003a) Cell surface-bound heat shock protein 70 (Hsp70) mediates perforin-independent apoptosis by specific binding and uptake of granzyme B. J Biol Chem 278:41173–41181
Gross C, Schmidt-Wolf IG, Nagaraj S, Gastpar R, Ellwart J, Kunz-Schughart LA, Multhoff G (2003b) Heat shock protein 70-reactivity is associated with increased cell surface density of CD94/CD56 on primary natural killer cells. Cell Stress Chaperones 8:348–360
Gross C, Hansch D, Gastpar R, Multhoff G (2003c) Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94. Biol Chem 384:267–279
Hartl FU, Hayer-Hartl M (2002) Molecular chaperones in the cytosol: from nascent chain to folded protein. Science 295:1852–1858
Heczkova B, Slotte JP (2006) Effect of anti-tumor ether lipids on ordered domains in model membranes. FEBS Lett 580:2471–2476
Hightower L, Guidon PT (1989) Selective release from cultured mammalian cells of heat shock (stress) proteins that resemble glia-axxon transfer protein. J Cell Physiol 138:257–266
Hirakawa T, Rokutan K, Nikawa T, Kishi K (1996) Geranylgeranylacetone induces heat shock proteins in cultured guinea pig gastric mucosal cells and rat gastric mucosa. Gastroenterology 111:345–357
Jaattela M (1999) Escaping cell death: survival proteins in cancer. Exp Cell Res 248:30–43
Jaattela M, Wissing D, Kokholm K, Kallunki T, Egeblad M (1998) Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases. EMBO J 17:6124–6134
Johnson TW, Anderson KE, Lazovich D, Folsom AR (2002) Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer. Cancer Epidemiol Biomark Prev 11:1586–1591
Kismet K, Akay MT, Abbasoglu O, Ercan A (2004) Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention. Cancer Detect Prev 28:127–142
Korbelik M, Sun J, Cecic I (2005) Photodynamic therapy-induced cell surface expression and release of HSPs: relevance for tumor response. Cancer Res 65:1018–1026
Krause SW, Gastpar R, Andreesen R, Gross C, Ullrich H, Thonigs G, Pfister K, Multhoff G (2004) Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase I trial. Clin Cancer Res 10:3699–3707
Lee CJ, Han JS, Seo CY, Park TH (2006) Pioglitazone, a synthetic ligand for PPARgamma, induces apoptosis in RB-deficient human colorectal cancer cells. Apoptosis 11:401–411
Mardini IA, FitzGerald GA (2001) Selective inhibitors of cyclooxygenase-2: a growing class of anti-inflammatory drugs. Mol Interv 1:30–38
Masferrer JL, Leahy KM, Koki AT (2000) Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 60:1306–1311
Massa C, Guiducci C, Arioli I, Parenza M, Colombo MP, Melani C (2004) Enhanced efficacy of tumro cell vaccines transfected with secretable hsp70. Cancer Res 64:15023–1508
Massaro GD, Massaro D (2000) Retinoic acid treatment partially rescues failed septation in rats and in mice. Am J Physiol Lung Cell Mol Physiol 278:955–960
Matsumoto H, Wang X, Ohnishi T (1995) Binding between wild-type p53 and hsp72 accumulated after UV and gamma-ray irradiation. Cancer Lett 92:127–133
Mollinedo F, Gajate C, Martin-Santamaria S, Gago F (2004) ET-18-OCH3 (edelfosine): a selective antitumour lipid targeting apoptosis through intracellular activation of Fas/CD95 death receptor. Curr Med Chem 11:3163–3184
Multhoff G, Botzler C, Wiesnet M, Muller E, Meier T, Wilmanns W, Issels RD (1995) A stress-inducible 72-kDa heat-shock protein (HSP72) is expressed on the surface of human tumor cells, but not on normal cells. Int J Cancer 61:272–279
Multhoff G, Botzler C, Allenbacher A, Issels R (1996) Effects of ifosfamide on immunocompetent effector cells. Cancer Immunol Immunother 42:251–254
Multhoff G, Botzler C, Jennen L, Schmidt J, Ellwart J, Issels R (1997) Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells. J Immunol 158:4341–4350
Multhoff G, Pfister K, Botzler C, Jordan A, Scholz R, Schmetzer H, Burgstahler R, Hiddemann W (2000) Adoptive transfer of human natural killer cells in mice with severe combined immunodeficiency inhibits growth of Hsp70-expressing tumors. Int J Cancer 88:791–797
Multhoff G, Pfister K, Gehrmann M, Hantsche lM, Gross C, Hafner M, Hiddemann W (2001) A 14-mer Hsp70 peptide stimulates natural killer (NK) cell activity. Cell Stress Chaperones 6:337–344
Nagpal S, Thacher SM, Patel S et al (1996) Negative regulation of two hyperproliferative keratinocyte differentiation markers by a retinoic acid receptor-specific retinoid: insight into the mechanism of retinoid action in psoriasis. Cell Growth Differ 7:1783–1791
O’Dwyer PJ, Stevenson JP, Johnson SW (2000) Clinical pharmacokinetics and administration of established platinum drugs. Drugs 59(Suppl 4):19–27
Okami J, Yamamoto H, Fujiwara Y et al (1999) Overexpression of cyclooxygenase-2 in carcinoma of the pancreas. Clin Cancer Res 5:2018–2024
Panayi GS, Corrigal VM (2006) Bip regulates autoimmune inflammation and tissue damage. Autoimmun Rev 5:140–142
Park DJ, Vuong PT, de Vos S, Douer D, Koeffler HP (2003) Comparative analysis of genes regulated by PML/RAR alpha and PLZF/RAR alpha in response to retinoic acid using oligonucleotide arrays. Blood 102:3727–3736
Park JE, Facciponte J, Chen X, MacDonald I, Repasky EA, Manjili MH, Wang XY, Subjeck JR (2006) Chaperoning function of stress protein grp170, a member of the HSP70 superfamily, is responsible for its immuno-adjuvant activity. Cancer Res 66:1161–1168
Parker WB, Secrist JA, Waud WR (2004) Purine nucleoside antimetabolites in development for the treatment of cancer. Curr Opin Investig Drugs 5:592–596
Patti R, Gumired K, Reddanna P, Sutton LN, Phillips PC, Reddy CD (2002) Overexpression of cyclooxygenase-2 (COX-2) in human primitive neuroectodermal tumors: effect of celecoxib and rofecoxib. Cancer Lett 180:13–21
Pfister K, Radons J, Busch R, Tidball J, Pfeifer M, Freitag L, Feldman HJ, Milani V, Issels R, Multhoff G (2007) Patient survival by Hsp70 membrane-phenotype: association with different routes of metastasis. Cancer 110:926–935
Quintana FJ, Carmi P, Mor F, Cohen IR (2004) Inhibition of adjuvant-induced arthritis by DNA vaccination with the 70 kDa or the 90 kDA HSP: immune cross-regulation with the 60 kDa HSP. Arthritis Rheum 50:3712–3720
Richter M, Weiss M, Weinberger I, Furstenberger G, Marian B (2001) Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors. Carcinogenesis 22:17–25
Shamma A, Yamamoto H, Doki Y et al (2000) Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus. Clin Cancer Res 6:1229–1238
Shin BK, Wang H, Yim AM et al (2003) Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function. J Biol Chem 278:7607–7616
Sierra-Rivera E, Voorhees GJ, Freeman ML (1993) Gamma irradiation increases hsp-70 in Chinese hamster ovary cells. Radiat Res 135:40–45
Song AM, Bhagat L, Singh VP, Van Acker GG, Steer ML, Saluja AK (2002) Inhibition of cyclooxygenase-2 ameliorates the severity of pancreatitis and associated lung injury. Am J Physiol Gastrointest Liver Physiol 283:G1166–G1174
Srivastava PK, Menoret A, Basu S, Binder RJ, McQuade KL (1998) Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world. Immunity 8:657–665
Stangl S, Wortmann A, Guertler U, Multhoff G (2006) Control of metastasized pancreatic carcinomas in SCID/beige mice with human IL-2/TKD-activated NK cells. J Immunol 176:6270–6276
Suzuki K, Watanabe M (1992) Augmented expression of HSP72 protein in normal human fibroblasts irradiated with ultraviolet light. Biochem Biophys Res Commun 186:1257–1264
Theriaults JR, Adachi H, Calderwood SK (2006) Role of scavenger receptors in the binding and internalization of HSP70. J Immunol 177:8604–8611
Thun MJ, Namboodiri MM, Heath CW Jr (1991) Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325:1593–1596
Todryk SM, Gough MJ, Pockley G (2003) Facets of Hsp70 show immunotherapeutic potentialImmunology. 110:1–9
Triantafilou M, Triantafilou K (2004) Hsp70 and Hsp90 associate with Toll-like receptor 4 in response to bacterial lipopolysaccharide. Biochem Soc Trans 32:636–639
Ulrich CM, Bigler J, Potter JD (2006) Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nat Rev Cancer 6:130–140
Vabulas RM, Wagner H, Schild H (2002) Heat shock proteins as ligands of toll-like receptors. Curr Top Microbiol Immunol 270:169–184
Wan YJ, Cai Y, Cowan C, Magee TR (2000) Fatty acyl-CoAs inhibit retinoic acid-induced apoptosis in Hep3B cells. Cancer Lett 154:19–27
Wang Z, Fuentes CF, Shapshay SM (2002) Antiangiogenic and chemopreventive activities of celecoxib in oral carcinoma cell. Laryngoscope 112:839–843
Wang M-H, Grossmann ME, Young CYF (2004) Forced expression of Hsp70increases the secretion of Hsp70 and provides protection against tumour growth. Brit J Cancer 90:926–931
Wang XY, Arnouk H, Chen X, Kazim L, Repasky EA, Subjeck JR (2006) Extracellular targeting of ER chaperone glucose-related protein 170 enhances tumor immunity to a poorly immunogenic melanoma. J Immunol 177:1543–1551
Wei YQ, Zhao X, Kariya Y, Teshigawara K, Uchida A (1995) Inhibition of proliferation and induction of apoptosis by abrogation of heat-shock protein (HSP) 70 expression in tumor cells. Cancer Immunol Immunother 40:73–78
Yamazaki R, Kusunoki N, Matsuzaki T, Hashimoto S, Kawai S (2002) Selective cyclooxygenase-2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cells. FEBS Lett 531:278–284
Zhang H, Huang W (2007) A 14-mer peptide form Hsp70 protein is the critical epitope which enhances NK activity against tumor cells in vivo. Immunol Invest 36:233–246
Zeng Y, Chen X, Larmonier N, Li G, Sepassi M, Marron M, Andraeansky S, Katsanis E (2006) NK cells play a key role in the antitumor immunity generated by chaperone-rich lysate vaccination. Int J Cancer 119:2624–2631
Zimmermann FB, Geinitz H, Schill S, Thamm R, Nieder C, Schratzenstaller U, Molls M (2006) Stereotactic hypofractionated radiotherapy in stage I (T1–2 N0 M0) non-small-cell lung cancer (NSCLC). Acta Oncol 45:796–801
Acknowledgment
This work was supported in part by the EU-Transnet project MRTN-2004-512253, the DFG project MU1238 7/2, and the multimmune GmbH, Munich. We want to thank Prof. Graham Pockley (University of Sheffield, UK, presently Technical University Munich) for constructive suggestions and for proofreading of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gehrmann, M., Radons, J., Molls, M. et al. The therapeutic implications of clinically applied modifiers of heat shock protein 70 (Hsp70) expression by tumor cells. Cell Stress and Chaperones 13, 1–10 (2008). https://doi.org/10.1007/s12192-007-0006-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12192-007-0006-0